Zimmer Biomet and Surgical Planning Associates Announce Exclusive Multi-Year Co-Marketing Agreement for HipInsight™ Mixed Reality System for Total Hip Replacement
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced an exclusive, multi-year co-marketing agreement with Surgical Planning Associates, Inc. to commercialize HipInsight™, the first FDA-cleared mixed reality navigation system for total hip replacement. HipInsight is customized for Zimmer Biomet’s hip implant portfolio and allows surgeons to use Microsoft HoloLens 2 glasses to visualize a hologram of the patient’s pelvic anatomy projected on the pelvis during surgery to support implant placement and alignment. HipInsight, the latest addition to the OptiVu™ Mixed Reality portfolio of applications, further expands the capabilities of the ZBEdge™ suite of integrated smart, digital and robotic technologies designed to deliver transformative data-powered insights with the goal of optimizing patient outcomes.
“The addition of HipInsight to our mixed reality portfolio advances our commitment to transform the surgical experience with the latest innovative technologies to help surgeons improve accuracy, strive for better outcomes and optimize efficiency during total hip arthroplasty,” said Nitin Goyal, MD, Chief Science, Technology and Innovation Officer at Zimmer Biomet. “This collaboration enables us to offer surgeons a sophisticated and proven mixed reality-based visualization tool customized for exclusive use with our hip implant portfolio.”
The HipInsight System provides a detailed, Computed Tomography (CT)-based, 3D surgical plan that includes information important for accurate and efficient implant positioning, including planned component size, pelvic tilt, leg length and offset change. During the surgery, the HipInsight system uses mixed-reality glasses and the position of a smart registration tool to overlay holograms in real time on the patient anatomy so that the surgeon can proceed with the surgical plan in direct view.
“We’re proud to partner with Zimmer Biomet, a leader in joint arthroplasty, to co-market HipInsight for their portfolio of hip implant systems,” said Stephen B. Murphy, M.D., founder of Surgical Planning Associates. “Unlike traditional intraoperative surgical navigation systems that provide information on flat screens outside the surgeon’s view, HipInsight leverages Microsoft HoloLens 2 mixed reality glasses in a truly innovative fashion to display images and information within the surgeons’ field of view to support accurate implant positioning. This collaboration is the next step in our journey to make mixed-reality-based surgical guidance the standard of care in orthopedics.”
- Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
- Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
- Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
- Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
- Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more